Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Update on Memryte program in Alzheimer's

May 22, 2007

Recent Pharmaleads and Pfizer patents disclose novel analgesic agents

May 22, 2007

Therapeutic autophagy by small-molecule enhancers shows promise for neurodegenerative diseases

May 22, 2007

SPD-465 receives approvable letter for ADHD

May 21, 2007

Seroquel XR receives FDA approval

May 21, 2007

MitoPharm's Schisandrin B may hold potential for antiaging concerns

May 21, 2007

Patient enrollment complete for Tovaxin MS trial

May 21, 2007

Novel therapeutic agents for neurological disorders reported in recent patent literature

May 21, 2007

Efficacy and MOA of BioLineRx's BL-1020 for schizophrenia sought in clinic

May 18, 2007

Dose-escalation trial to establish optimal dose of AL-02

May 18, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...